Author:
Moratin Julius,Horn Dominik,Oehme Marcel,Semmelmayer Karl,Flechtenmacher Christa,Ristow Oliver,Held Thomas,Engel Michael,Hoffmann Jürgen,Freudlsperger Christian
Abstract
Abstract
Objectives
Surgical resection is a key component of the treatment of head and neck cancer and the achievement of free surgical margins are essential for the patients’ outcome in terms of survival. While there is a general recommendation for a free resection range of 5 mm, up to date, there is a lack of investigations on the quality of tumor resection in dependence of affected subsite and tumor stage. In the presented study, predictors for the achieved resection margins in surgically treated oral squamous cell carcinomas were analyzed.
Materials and methods
A cohort of 567 patients was included in a retrospective analysis and resection status with exact margin ranges were analysed. Tumor stage, affected subsite and the results of the intraoperative frozen section analysis were assessed. Primary endpoint was the achieved resection margin in mm, secondary endpoints were overall and progression-free survival.
Results
The observed mean values of minimal resection margins differed significantly between the investigated subsites (p = 0.042),pathological tumor stages (p < 0.001) and in tumors which demonstrated perineural infiltration (Pn1, p = 0.002). Furthermore, there was a significant impact of the results of the intraoperative frozen section analysis on progression-free and overall survival (p < 0.001).
Conclusions
Our data clearly indicate that resection status differs between tumors of different subsites and tumor stages.
Clinical relevance
Clinical procedures should be adapted in order to achieve similar certainty in all resections, and, thus to improve patients’ outcome.
Funder
Medizinische Fakultät Heidelberg der Universität Heidelberg
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917
2. Forastiere A, Koch W, Trotti A, Sidransky D (2001) Head and neck cancer. N Engl J Med 345:1890–1900
3. Pignon JP, le Maitre A, Maillard E, Bourhis J, Group M-NC (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92:4–14
4. D’Cruz AK, Vaish R, Kapre N, Dandekar M, Gupta S, Hawaldar R et al (2015) Elective versus therapeutic neck dissection in node-negative oral cancer. N Engl J Med 373:521–529
5. Akhtar S, Ikram M, Ghaffar S (2007) Neck involvement in early carcinoma of tongue. Is elective neck dissection warranted? J Pak Med Assoc. 57:305–7